• One of the cleavage fibrinogen products, termed 'desAA-Fibrin', acts as cofactor for the tPA-induced plasminogen activation and an increased fibrinolysis results in return (profibrinolytic activity of ancrod). (wikipedia.org)
  • The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Ancrod. (drugbank.com)